{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:23:16Z","timestamp":1771680196131,"version":"3.50.1"},"reference-count":27,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,7,31]]},"DOI":"10.7883\/yoken.jjid.2020.884","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T22:16:09Z","timestamp":1608848169000},"page":"307-315","source":"Crossref","is-referenced-by-count":43,"title":["Increased Secondary Infection in COVID-19 Patients Treated with Steroids in New York City"],"prefix":"10.7883","volume":"74","author":[{"given":"Reiichiro","family":"Obata","sequence":"first","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahlia","family":"Rizk","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.","DOI":"10.1056\/NEJMoa2001017"},{"key":"2","unstructured":"2. Religions for Peace. Coronavirus COVID-19 global cases by the Center for Systems Science and Enginerring at Johns Hopkins University. Available at &lt;https:\/\/www.rfp.org\/resources\/coronavirus-covid-19-global-cases-by-the-center-for-systems-science-and-engineering-csse-at-johns-hopkins-university-jhu\/&gt;. Accessed April 27, 2021."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606.","DOI":"10.1136\/bmj.m606"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim GU, Kim MJ, Ra SH, et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020;26:948 e1-948 e3.","DOI":"10.1016\/j.cmi.2020.04.040"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhou W, Liu Y, Tian D, et al. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduct Target Ther. 2020;5:18.","DOI":"10.1038\/s41392-020-0127-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-43.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. The RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with covid-19 - preliminary report. N Engl J Med. 2021;384:693-704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"9","unstructured":"9. National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at &lt;https:\/\/www.covid19treatmentguidelines.nih.gov\/&gt;. Accessed September 14, 2020."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020;ciaa478.","DOI":"10.1093\/cid\/ciaa478"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jangi S. Facing uncertainty--dispatch from Beth Israel Medical Center, Manhattan. N Engl J Med. 2012;367:2267-9.","DOI":"10.1056\/NEJMp1213844"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801-10.","DOI":"10.1001\/jama.2016.0287"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hartikainen TS, S\u00f6rensen NA, Haller PM, et al. Clinical application of the 4th universal definition of myocardial infarction. Eur Heart J. 2020;41:2209-16.","DOI":"10.1093\/eurheartj\/ehaa035"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:56:105949.","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cleverley J, Piper J, Jones MM. The role of chest radiography in confirming covid-19 pneumonia. BMJ. 2020;370:m2426.","DOI":"10.1136\/bmj.m2426"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Capecchi PL, Lazzerini PE, Volterrani L, et al. Antirheumatic agents in covid-19: is IL-6 the right target? Ann Rheum Dis. 2021;80:e2.","DOI":"10.1136\/annrheumdis-2020-217523"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020;92:2283-5.","DOI":"10.1002\/jmv.25948"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Grasselli G, Zangrillo A, Zanella A,<b> <\/b>et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574-81.","DOI":"10.1001\/jama.2020.5394"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanne JH. Covid-19: New York City deaths pass 1000 as Trump tells Americans to distance for 30 days. BMJ. 2020;369:m1333.","DOI":"10.1136\/bmj.m1333"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Murakami N, Siktel HB, Lucido D, et al. Disaster preparedness and awareness of patients on hemodialysis after Hurricane Sandy. Clin J Am Soc Nephrol. 2015;10:1389-96.","DOI":"10.2215\/CJN.10181014"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383:2451-60.","DOI":"10.1056\/NEJMcp2009575"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473-5.","DOI":"10.1016\/S0140-6736(20)30317-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 2018;197:757-67.","DOI":"10.1164\/rccm.201706-1172OC"},{"key":"25","unstructured":"25. The Writing Committee for the REMAP-CAP Investigators; Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324:1317-29."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dequin PF, Heming N, Meziani F, et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. JAMA. 2020;324:1298-1306.","DOI":"10.1001\/jama.2020.16761"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307-16.","DOI":"10.1001\/jama.2020.17021"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/4\/74_JJID.2020.884\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:19:45Z","timestamp":1670563185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/4\/74_JJID.2020.884\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.884","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"article-number":"JJID.2020.884"}}